Stay updated on Safety and Tolerability of ABBV-467 in R/R Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Safety and Tolerability of ABBV-467 in R/R Multiple Myeloma Clinical Trial page.

Latest updates to the Safety and Tolerability of ABBV-467 in R/R Multiple Myeloma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision entry, v3.4.2, was added to the study history, while the operating-status notice and the prior revision entry (v3.4.1) were removed.SummaryDifference0.8%

- Check21 days agoChange DetectedAdded a government-funding lapse notice and the NIH Clinical Center status, and updated the page revision to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.8%

- Check28 days agoChange DetectedAdded a Show glossary option and color-coded highlights to differentiate additions (green) and deletions (red) in the study record history. The revision notes now show Revision: v3.4.0 and remove the previous v3.3.4 note.SummaryDifference1%

- Check42 days agoChange DetectedA new revision entry (v3.3.4) was added to the study record history, and v3.3.3 was removed, reflecting an update to the record without changing study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.3.3 was added to the Study Record Versions list, indicating an update to the page. The footer now omits the HHS Vulnerability Disclosure link and the older Revision: v3.3.2.SummaryDifference0.2%

- Check85 days agoChange DetectedThe revision history shows an update from v3.3.1 to v3.3.2 with no changes to study content or visible page details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Safety and Tolerability of ABBV-467 in R/R Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Tolerability of ABBV-467 in R/R Multiple Myeloma Clinical Trial page.